Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A.
Mast cells are granular immunocytes that reside in the body's barrier tissues. These cells orchestrate inflammatory responses. Proinflammatory mediators are stored in granular structures within the mast cell cytosol. Control of mast cell granule exocytosis is a major therapeutic goal for allergic and inflammatory diseases. However, the proteins that control granule biogenesis and abundance in mast cells have not been elucidated. In neuroendocrine cells, whose dense core granules are strikingly similar to mast cell granules, granin proteins regulate granulogenesis. Our studies suggest that the Secretogranin III (SgIII) protein is involved in secretory granule biogenesis in mast cells. SgIII is abundant in mast cells, and is organized into vesicular structures. Our results show that over-expression of SgIII in mast cells is sufficient to cause an expansion of a granular compartment in these cells. These novel granules store inflammatory mediators that are released in response to physiological stimuli, indicating that they function as bona fide secretory vesicles. In mast cells, as in neuroendocrine cells, we show that SgIII is complexed with Chromogranin A (CgA). CgA is granulogenic when complexed with SgIII. Our data show that a novel non-granulogenic truncation mutant of SgIII (1-210) lacks the ability to interact with CgA. Thus, in mast cells, a CgA-SgIII complex may play a key role in secretory granule biogenesis. SgIII function in mast cells is unlikely to be limited to its partnership with CgA, as our interaction trap analysis suggests that SgIII has multiple binding partners, including the mast cell ion channel TRPA1.
Prasad
Prerna
P
Center for Biomedical Research at The Queen's Medical Center, Honolulu, HI 96813, USA.
Yanagihara
Angel A
AA
Small-Howard
Andrea L
AL
Turner
Helen
H
Stokes
Alexander J
AJ
D000818:Animals; D002450:Cell Communication / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D045744:Cell Line, Tumor; D053379:Chromogranin A / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D002864:Chromogranins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D007946:Leukemia, Mast-Cell / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D008407:Mast Cells / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D034801:Mastocytoma / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D051379:Mice; D016716:PC12 Cells; D051381:Rats; D022142:Secretory Vesicles / Q000235:genetics / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D017384:Sequence Deletion
D053379:Chromogranin A; D002864:Chromogranins; C506153:chromogranin A, rat; C506142:secretogranin 3, rat